---
schema_version: "secwatch.filing_event.v1"
accession: "0000784199-24-000169"
form_type: "8-K"
ticker: "AORT"
cik: "0000784199"
company_name: "ARTIVION, INC."
filed_at: "2024-05-06T23:59:59+00:00"
generated_at: "2026-06-02T22:36:58.231125+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Artivion Q1 revenue $97.4M (+17% YoY); nets $7.5M income vs loss; raises FY24 guidance

## Summary
- Revenue $97.4M, up 17% GAAP (16% constant currency) vs $83.2M in Q1 2023.
- Net income $7.5M ($0.18 diluted EPS) vs net loss ($13.5M) in Q1 2023; non-GAAP net income $2.6M ($0.06 EPS).
- Non-GAAP adjusted EBITDA rose 60% to $17.3M from $10.8M in Q1 2023.
- Revised FY24 constant-currency revenue growth guidance to 9%-12% (prev 8%-12%); revenue range $386M-$396M.
- Tissue processing +26% constant currency YoY; stent grafts +19%; Latin America +22% constant currency.

## SEC filing metadata
- accession: 0000784199-24-000169
- form_type: 8-K
- ticker: AORT
- cik: 0000784199
- company_name: ARTIVION, INC.
- filed_at: 2024-05-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/784199/000078419924000169/0000784199-24-000169-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/784199/000078419924000169/aort-20240506.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000784199-24-000169
- JSON: https://secwatch.observer/filing/0000784199-24-000169.json
- Plain text: https://secwatch.observer/filing/0000784199-24-000169.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.